Inventor · disambiguated record
Rajesh Devraj
Also filed as: DEVRAJ RAJESH · DEVRAJ RAJESH V
34 granted patents·13 pending applications·444 citations·filing 1998–2024
97Inventor score
Files withDISARM THERAPEUTICS INC12PADLOCK THERAPEUTICS INC7PHARMACIA CORP6ASANA BIOSCIENCES LLC5SEARLE & CO4
Top patents by PatentIndex Score
47 records- 0196US6979686B1Substituted pyrazoles as p38 kinase inhibitorsPHARMACIA CORP·Filed 2001·Granted Dec 27, 2005·64 cites·63 claims
- 0296US6423713B1Substituted pyrazoles as p38 kinase inhibitorsSEARLE & CO·Filed 2001·Granted Jul 23, 2002·90 cites·88 claims
- 0395US6525059B1Substituted pyrazoles as p38 kinase inhibitorsSEARLE & CO·Filed 2000·Granted Feb 25, 2003·62 cites·79 claims
- 0493US6617324B1Substituted pyrazoles as p38 kinase inhibitorsSEARLE & CO·Filed 2002·Granted Sep 9, 2003·47 cites·112 claims
- 0590US7598231B2Tricyclic compound, compositions, and methodsPFIZER·Filed 2008·Granted Oct 6, 2009·13 cites·6 claims
- 0690US7067540B2Substituted pyridinonesPHARMACIA CORP·Filed 2003·Granted Jun 27, 2006·44 cites·45 claims
- 0790US6514977B1Substituted pyrazoles as p38 kinase inhibitorsSEARLE & CO·Filed 1998·Granted Feb 4, 2003·70 cites·92 claims
- 0889US11903935B2Inhibitors of SARM1 NADase activity and uses thereofWASHINGTON UNIVERSITY ST LOUIS·Filed 2021·Granted Feb 20, 2024·2 cites·3 claims
- 0987US11253503B2Inhibitors of SARM1 NADase activity and uses thereofUNIV WASHINGTON·Filed 2017·Granted Feb 22, 2022·5 cites·2 claims
- 1086US12083114B2Inhibitors of SARM1 in combination with neuro-protective agentsDISARM THERAPEUTICS INC·Filed 2019·Granted Sep 10, 2024·5 cites·9 claims
- 1185US8809372B2Pyridine derivativesENDO PHARMACEUTICALS INC·Filed 2012·Granted Aug 19, 2014·3 cites·37 claims
- 1284US7786097B2Tricyclic compounds, compositions and methodsPFIZER·Filed 2009·Granted Aug 31, 2010·5 cites·8 claims
- 1381US7629363B2Diaryl substituted pyridinonesPFIZER·Filed 2005·Granted Dec 8, 2009·5 cites·31 claims
- 1479US7071198B1Substituted pyrazoles as p38 kinase inhibitorsPHARMACIA CORP·Filed 2004·Granted Jul 4, 2006·7 cites·7 claims
- 1578US11198681B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Dec 14, 2021·4 cites·15 claims
- 1676US7153959B2Substituted pyrazoles as p38 kinase inhibitorsPHARMACIA CORP·Filed 2003·Granted Dec 26, 2006·6 cites·9 claims
- 1774US2024238264A1Inhibitors of sarm1 nadase activity and uses thereofWASHINGTON UNIVERSITY ST LOUIS·Filed 2024·Application pending·0 cites
- 1872US2024376083A1Inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1971US11026937B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Jun 8, 2021·1 cites·7 claims
- 2070US9963448B2Bicyclic inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2016·Granted May 8, 2018·2 cites·20 claims
- 2170US8293903B23-aminocyclopentanecarboxamides as chemokine receptor agonistsHUGHES ROBERT O·Filed 2010·Granted Oct 23, 2012·2 cites·4 claims
- 2269US9371316B2Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2014·Granted Jun 21, 2016·0 cites·18 claims
- 2369US9266873B2Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2014·Granted Feb 23, 2016·0 cites·10 claims
- 2468US10703741B2Covalent inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Jul 7, 2020·1 cites·13 claims
- 2566US12043613B2Inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2021·Granted Jul 23, 2024·0 cites·19 claims
- 2666US9765093B2Aza-benzimidazole inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2016·Granted Sep 19, 2017·1 cites·17 claims
- 2765US9533981B2Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2013·Granted Jan 3, 2017·0 cites·21 claims
- 2865US8946413B23-aminocyclopentanecarboxamides as chemokine receptor agonistsHUGHES ROBERT O·Filed 2012·Granted Feb 3, 2015·1 cites·13 claims
- 2962US11897866B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2021·Granted Feb 13, 2024·0 cites·15 claims
- 3060US12331033B2Inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2021·Granted Jun 17, 2025·0 cites·6 claims
- 3160US2021299115A1Heteroaryl inhibitors of pad4PADLOCK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3260US2017073339A1Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2016·Application pending·0 cites
- 3358US12448374B2Inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2019·Granted Oct 21, 2025·0 cites·2 claims
- 3455US12435084B2Indazole derivatives as inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2021·Granted Oct 7, 2025·0 cites·10 claims
- 3554US12441719B2Inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2020·Granted Oct 14, 2025·0 cites·10 claims
- 3654US2024051939A1Benzopyrazole inhibitors of sarm1DISARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3753US2007088033A1Diaryl Substituted PyridinonesDEVADAS BALEKUDRU·Filed 2006·Application pending·0 cites
- 3852US12338238B2Inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2019·Granted Jun 24, 2025·0 cites·16 claims
- 3951US6362218B1Brefeldin A derivativesPURDUE RESEARCH FOUNDATION·Filed 1998·Granted Mar 26, 2002·4 cites·8 claims
- 4049US9199975B2Biaryl imidazole derivatives for regulating CYP17ASANA BIOSCIENCES LLC·Filed 2012·Granted Dec 1, 2015·0 cites·18 claims
- 4149US2005256122A1Substituted pyridazinonesPHARMACIA CORP·Filed 2005·Application pending·0 cites
- 4248US2022242859A1Inhibitors of sarm1DISARM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4348US2022072019A1Inhibitors of sarm1 in combination with nad+ or a nad+ precursorDISARM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4447US2004142932A1Substituted pyridazinonesFiled 2003·Application pending·0 cites
- 4544US2005176775A1Substituted pyridinonesFiled 2004·Application pending·0 cites
- 4643US2021261537A1Inhibitors of sarm1DISARM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4743US2005020594A1Substituted pyridazinonesPHARMACIA CORP·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rajesh Devraj files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →